Request for Covid-19 Impact Assessment of this Report
The United States Hepatitis B Vaccination market is expected at value of US$ million in 2021 and grow at approximately % CAGR during forecast period 2022-2028. China constitutes a % market for the global Hepatitis B Vaccination market, reaching US$ million by the year 2028. As for the Europe Hepatitis B Vaccination landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 6-year period.
Global main Hepatitis B Vaccination players cover GSK, NCPC, Merck, and Bio Kangtai, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Hepatitis B Vaccination market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Yeast Derived
CHO Derived
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Children
Adult
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
GSK
NCPC
Merck
Bio Kangtai
Dynavax
Hissen
KM Biologics
LG Life Sciences
Serum Institute
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Hepatitis B Vaccination Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Hepatitis B Vaccination by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Hepatitis B Vaccination by Country/Region, 2017, 2022 & 2028
2.2 Hepatitis B Vaccination Segment by Type
2.2.1 Yeast Derived
2.2.2 CHO Derived
2.3 Hepatitis B Vaccination Sales by Type
2.3.1 Global Hepatitis B Vaccination Sales Market Share by Type (2017-2022)
2.3.2 Global Hepatitis B Vaccination Revenue and Market Share by Type (2017-2022)
2.3.3 Global Hepatitis B Vaccination Sale Price by Type (2017-2022)
2.4 Hepatitis B Vaccination Segment by Application
2.4.1 Children
2.4.2 Adult
2.5 Hepatitis B Vaccination Sales by Application
2.5.1 Global Hepatitis B Vaccination Sale Market Share by Application (2017-2022)
2.5.2 Global Hepatitis B Vaccination Revenue and Market Share by Application (2017-2022)
2.5.3 Global Hepatitis B Vaccination Sale Price by Application (2017-2022)
3 Global Hepatitis B Vaccination by Company
3.1 Global Hepatitis B Vaccination Breakdown Data by Company
3.1.1 Global Hepatitis B Vaccination Annual Sales by Company (2020-2022)
3.1.2 Global Hepatitis B Vaccination Sales Market Share by Company (2020-2022)
3.2 Global Hepatitis B Vaccination Annual Revenue by Company (2020-2022)
3.2.1 Global Hepatitis B Vaccination Revenue by Company (2020-2022)
3.2.2 Global Hepatitis B Vaccination Revenue Market Share by Company (2020-2022)
3.3 Global Hepatitis B Vaccination Sale Price by Company
3.4 Key Manufacturers Hepatitis B Vaccination Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Hepatitis B Vaccination Product Location Distribution
3.4.2 Players Hepatitis B Vaccination Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Hepatitis B Vaccination by Geographic Region
4.1 World Historic Hepatitis B Vaccination Market Size by Geographic Region (2017-2022)
4.1.1 Global Hepatitis B Vaccination Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Hepatitis B Vaccination Annual Revenue by Geographic Region
4.2 World Historic Hepatitis B Vaccination Market Size by Country/Region (2017-2022)
4.2.1 Global Hepatitis B Vaccination Annual Sales by Country/Region (2017-2022)
4.2.2 Global Hepatitis B Vaccination Annual Revenue by Country/Region
4.3 Americas Hepatitis B Vaccination Sales Growth
4.4 APAC Hepatitis B Vaccination Sales Growth
4.5 Europe Hepatitis B Vaccination Sales Growth
4.6 Middle East & Africa Hepatitis B Vaccination Sales Growth
5 Americas
5.1 Americas Hepatitis B Vaccination Sales by Country
5.1.1 Americas Hepatitis B Vaccination Sales by Country (2017-2022)
5.1.2 Americas Hepatitis B Vaccination Revenue by Country (2017-2022)
5.2 Americas Hepatitis B Vaccination Sales by Type
5.3 Americas Hepatitis B Vaccination Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Hepatitis B Vaccination Sales by Region
6.1.1 APAC Hepatitis B Vaccination Sales by Region (2017-2022)
6.1.2 APAC Hepatitis B Vaccination Revenue by Region (2017-2022)
6.2 APAC Hepatitis B Vaccination Sales by Type
6.3 APAC Hepatitis B Vaccination Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Hepatitis B Vaccination by Country
7.1.1 Europe Hepatitis B Vaccination Sales by Country (2017-2022)
7.1.2 Europe Hepatitis B Vaccination Revenue by Country (2017-2022)
7.2 Europe Hepatitis B Vaccination Sales by Type
7.3 Europe Hepatitis B Vaccination Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Hepatitis B Vaccination by Country
8.1.1 Middle East & Africa Hepatitis B Vaccination Sales by Country (2017-2022)
8.1.2 Middle East & Africa Hepatitis B Vaccination Revenue by Country (2017-2022)
8.2 Middle East & Africa Hepatitis B Vaccination Sales by Type
8.3 Middle East & Africa Hepatitis B Vaccination Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Hepatitis B Vaccination
10.3 Manufacturing Process Analysis of Hepatitis B Vaccination
10.4 Industry Chain Structure of Hepatitis B Vaccination
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Hepatitis B Vaccination Distributors
11.3 Hepatitis B Vaccination Customer
12 World Forecast Review for Hepatitis B Vaccination by Geographic Region
12.1 Global Hepatitis B Vaccination Market Size Forecast by Region
12.1.1 Global Hepatitis B Vaccination Forecast by Region (2023-2028)
12.1.2 Global Hepatitis B Vaccination Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Hepatitis B Vaccination Forecast by Type
12.7 Global Hepatitis B Vaccination Forecast by Application
13 Key Players Analysis
13.1 GSK
13.1.1 GSK Company Information
13.1.2 GSK Hepatitis B Vaccination Product Offered
13.1.3 GSK Hepatitis B Vaccination Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 GSK Main Business Overview
13.1.5 GSK Latest Developments
13.2 NCPC
13.2.1 NCPC Company Information
13.2.2 NCPC Hepatitis B Vaccination Product Offered
13.2.3 NCPC Hepatitis B Vaccination Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 NCPC Main Business Overview
13.2.5 NCPC Latest Developments
13.3 Merck
13.3.1 Merck Company Information
13.3.2 Merck Hepatitis B Vaccination Product Offered
13.3.3 Merck Hepatitis B Vaccination Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Merck Main Business Overview
13.3.5 Merck Latest Developments
13.4 Bio Kangtai
13.4.1 Bio Kangtai Company Information
13.4.2 Bio Kangtai Hepatitis B Vaccination Product Offered
13.4.3 Bio Kangtai Hepatitis B Vaccination Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Bio Kangtai Main Business Overview
13.4.5 Bio Kangtai Latest Developments
13.5 Dynavax
13.5.1 Dynavax Company Information
13.5.2 Dynavax Hepatitis B Vaccination Product Offered
13.5.3 Dynavax Hepatitis B Vaccination Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Dynavax Main Business Overview
13.5.5 Dynavax Latest Developments
13.6 Hissen
13.6.1 Hissen Company Information
13.6.2 Hissen Hepatitis B Vaccination Product Offered
13.6.3 Hissen Hepatitis B Vaccination Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Hissen Main Business Overview
13.6.5 Hissen Latest Developments
13.7 KM Biologics
13.7.1 KM Biologics Company Information
13.7.2 KM Biologics Hepatitis B Vaccination Product Offered
13.7.3 KM Biologics Hepatitis B Vaccination Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 KM Biologics Main Business Overview
13.7.5 KM Biologics Latest Developments
13.8 LG Life Sciences
13.8.1 LG Life Sciences Company Information
13.8.2 LG Life Sciences Hepatitis B Vaccination Product Offered
13.8.3 LG Life Sciences Hepatitis B Vaccination Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 LG Life Sciences Main Business Overview
13.8.5 LG Life Sciences Latest Developments
13.9 Serum Institute
13.9.1 Serum Institute Company Information
13.9.2 Serum Institute Hepatitis B Vaccination Product Offered
13.9.3 Serum Institute Hepatitis B Vaccination Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Serum Institute Main Business Overview
13.9.5 Serum Institute Latest Developments
14 Research Findings and Conclusion
Table 1. Hepatitis B Vaccination Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Hepatitis B Vaccination Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Yeast Derived
Table 4. Major Players of CHO Derived
Table 5. Global Hepatitis B Vaccination Sales by Type (2017-2022) & (Units)
Table 6. Global Hepatitis B Vaccination Sales Market Share by Type (2017-2022)
Table 7. Global Hepatitis B Vaccination Revenue by Type (2017-2022) & ($ million)
Table 8. Global Hepatitis B Vaccination Revenue Market Share by Type (2017-2022)
Table 9. Global Hepatitis B Vaccination Sale Price by Type (2017-2022) & (US$/Unit)
Table 10. Global Hepatitis B Vaccination Sales by Application (2017-2022) & (Units)
Table 11. Global Hepatitis B Vaccination Sales Market Share by Application (2017-2022)
Table 12. Global Hepatitis B Vaccination Revenue by Application (2017-2022)
Table 13. Global Hepatitis B Vaccination Revenue Market Share by Application (2017-2022)
Table 14. Global Hepatitis B Vaccination Sale Price by Application (2017-2022) & (US$/Unit)
Table 15. Global Hepatitis B Vaccination Sales by Company (2020-2022) & (Units)
Table 16. Global Hepatitis B Vaccination Sales Market Share by Company (2020-2022)
Table 17. Global Hepatitis B Vaccination Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Hepatitis B Vaccination Revenue Market Share by Company (2020-2022)
Table 19. Global Hepatitis B Vaccination Sale Price by Company (2020-2022) & (US$/Unit)
Table 20. Key Manufacturers Hepatitis B Vaccination Producing Area Distribution and Sales Area
Table 21. Players Hepatitis B Vaccination Products Offered
Table 22. Hepatitis B Vaccination Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Hepatitis B Vaccination Sales by Geographic Region (2017-2022) & (Units)
Table 26. Global Hepatitis B Vaccination Sales Market Share Geographic Region (2017-2022)
Table 27. Global Hepatitis B Vaccination Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Hepatitis B Vaccination Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Hepatitis B Vaccination Sales by Country/Region (2017-2022) & (Units)
Table 30. Global Hepatitis B Vaccination Sales Market Share by Country/Region (2017-2022)
Table 31. Global Hepatitis B Vaccination Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Hepatitis B Vaccination Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Hepatitis B Vaccination Sales by Country (2017-2022) & (Units)
Table 34. Americas Hepatitis B Vaccination Sales Market Share by Country (2017-2022)
Table 35. Americas Hepatitis B Vaccination Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Hepatitis B Vaccination Revenue Market Share by Country (2017-2022)
Table 37. Americas Hepatitis B Vaccination Sales by Type (2017-2022) & (Units)
Table 38. Americas Hepatitis B Vaccination Sales Market Share by Type (2017-2022)
Table 39. Americas Hepatitis B Vaccination Sales by Application (2017-2022) & (Units)
Table 40. Americas Hepatitis B Vaccination Sales Market Share by Application (2017-2022)
Table 41. APAC Hepatitis B Vaccination Sales by Region (2017-2022) & (Units)
Table 42. APAC Hepatitis B Vaccination Sales Market Share by Region (2017-2022)
Table 43. APAC Hepatitis B Vaccination Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Hepatitis B Vaccination Revenue Market Share by Region (2017-2022)
Table 45. APAC Hepatitis B Vaccination Sales by Type (2017-2022) & (Units)
Table 46. APAC Hepatitis B Vaccination Sales Market Share by Type (2017-2022)
Table 47. APAC Hepatitis B Vaccination Sales by Application (2017-2022) & (Units)
Table 48. APAC Hepatitis B Vaccination Sales Market Share by Application (2017-2022)
Table 49. Europe Hepatitis B Vaccination Sales by Country (2017-2022) & (Units)
Table 50. Europe Hepatitis B Vaccination Sales Market Share by Country (2017-2022)
Table 51. Europe Hepatitis B Vaccination Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Hepatitis B Vaccination Revenue Market Share by Country (2017-2022)
Table 53. Europe Hepatitis B Vaccination Sales by Type (2017-2022) & (Units)
Table 54. Europe Hepatitis B Vaccination Sales Market Share by Type (2017-2022)
Table 55. Europe Hepatitis B Vaccination Sales by Application (2017-2022) & (Units)
Table 56. Europe Hepatitis B Vaccination Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Hepatitis B Vaccination Sales by Country (2017-2022) & (Units)
Table 58. Middle East & Africa Hepatitis B Vaccination Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Hepatitis B Vaccination Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Hepatitis B Vaccination Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Hepatitis B Vaccination Sales by Type (2017-2022) & (Units)
Table 62. Middle East & Africa Hepatitis B Vaccination Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Hepatitis B Vaccination Sales by Application (2017-2022) & (Units)
Table 64. Middle East & Africa Hepatitis B Vaccination Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Hepatitis B Vaccination
Table 66. Key Market Challenges & Risks of Hepatitis B Vaccination
Table 67. Key Industry Trends of Hepatitis B Vaccination
Table 68. Hepatitis B Vaccination Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Hepatitis B Vaccination Distributors List
Table 71. Hepatitis B Vaccination Customer List
Table 72. Global Hepatitis B Vaccination Sales Forecast by Region (2023-2028) & (Units)
Table 73. Global Hepatitis B Vaccination Sales Market Forecast by Region
Table 74. Global Hepatitis B Vaccination Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Hepatitis B Vaccination Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Hepatitis B Vaccination Sales Forecast by Country (2023-2028) & (Units)
Table 77. Americas Hepatitis B Vaccination Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Hepatitis B Vaccination Sales Forecast by Region (2023-2028) & (Units)
Table 79. APAC Hepatitis B Vaccination Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Hepatitis B Vaccination Sales Forecast by Country (2023-2028) & (Units)
Table 81. Europe Hepatitis B Vaccination Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Hepatitis B Vaccination Sales Forecast by Country (2023-2028) & (Units)
Table 83. Middle East & Africa Hepatitis B Vaccination Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Hepatitis B Vaccination Sales Forecast by Type (2023-2028) & (Units)
Table 85. Global Hepatitis B Vaccination Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Hepatitis B Vaccination Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Hepatitis B Vaccination Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Hepatitis B Vaccination Sales Forecast by Application (2023-2028) & (Units)
Table 89. Global Hepatitis B Vaccination Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Hepatitis B Vaccination Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Hepatitis B Vaccination Revenue Market Share Forecast by Application (2023-2028)
Table 92. GSK Basic Information, Hepatitis B Vaccination Manufacturing Base, Sales Area and Its Competitors
Table 93. GSK Hepatitis B Vaccination Product Offered
Table 94. GSK Hepatitis B Vaccination Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 95. GSK Main Business
Table 96. GSK Latest Developments
Table 97. NCPC Basic Information, Hepatitis B Vaccination Manufacturing Base, Sales Area and Its Competitors
Table 98. NCPC Hepatitis B Vaccination Product Offered
Table 99. NCPC Hepatitis B Vaccination Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 100. NCPC Main Business
Table 101. NCPC Latest Developments
Table 102. Merck Basic Information, Hepatitis B Vaccination Manufacturing Base, Sales Area and Its Competitors
Table 103. Merck Hepatitis B Vaccination Product Offered
Table 104. Merck Hepatitis B Vaccination Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 105. Merck Main Business
Table 106. Merck Latest Developments
Table 107. Bio Kangtai Basic Information, Hepatitis B Vaccination Manufacturing Base, Sales Area and Its Competitors
Table 108. Bio Kangtai Hepatitis B Vaccination Product Offered
Table 109. Bio Kangtai Hepatitis B Vaccination Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 110. Bio Kangtai Main Business
Table 111. Bio Kangtai Latest Developments
Table 112. Dynavax Basic Information, Hepatitis B Vaccination Manufacturing Base, Sales Area and Its Competitors
Table 113. Dynavax Hepatitis B Vaccination Product Offered
Table 114. Dynavax Hepatitis B Vaccination Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 115. Dynavax Main Business
Table 116. Dynavax Latest Developments
Table 117. Hissen Basic Information, Hepatitis B Vaccination Manufacturing Base, Sales Area and Its Competitors
Table 118. Hissen Hepatitis B Vaccination Product Offered
Table 119. Hissen Hepatitis B Vaccination Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 120. Hissen Main Business
Table 121. Hissen Latest Developments
Table 122. KM Biologics Basic Information, Hepatitis B Vaccination Manufacturing Base, Sales Area and Its Competitors
Table 123. KM Biologics Hepatitis B Vaccination Product Offered
Table 124. KM Biologics Hepatitis B Vaccination Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 125. KM Biologics Main Business
Table 126. KM Biologics Latest Developments
Table 127. LG Life Sciences Basic Information, Hepatitis B Vaccination Manufacturing Base, Sales Area and Its Competitors
Table 128. LG Life Sciences Hepatitis B Vaccination Product Offered
Table 129. LG Life Sciences Hepatitis B Vaccination Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 130. LG Life Sciences Main Business
Table 131. LG Life Sciences Latest Developments
Table 132. Serum Institute Basic Information, Hepatitis B Vaccination Manufacturing Base, Sales Area and Its Competitors
Table 133. Serum Institute Hepatitis B Vaccination Product Offered
Table 134. Serum Institute Hepatitis B Vaccination Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 135. Serum Institute Main Business
Table 136. Serum Institute Latest Developments
List of Figures
Figure 1. Picture of Hepatitis B Vaccination
Figure 2. Hepatitis B Vaccination Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Hepatitis B Vaccination Sales Growth Rate 2017-2028 (Units)
Figure 7. Global Hepatitis B Vaccination Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Hepatitis B Vaccination Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Yeast Derived
Figure 10. Product Picture of CHO Derived
Figure 11. Global Hepatitis B Vaccination Sales Market Share by Type in 2021
Figure 12. Global Hepatitis B Vaccination Revenue Market Share by Type (2017-2022)
Figure 13. Hepatitis B Vaccination Consumed in Children
Figure 14. Global Hepatitis B Vaccination Market: Children (2017-2022) & (Units)
Figure 15. Hepatitis B Vaccination Consumed in Adult
Figure 16. Global Hepatitis B Vaccination Market: Adult (2017-2022) & (Units)
Figure 17. Global Hepatitis B Vaccination Sales Market Share by Application (2017-2022)
Figure 18. Global Hepatitis B Vaccination Revenue Market Share by Application in 2021
Figure 19. Hepatitis B Vaccination Revenue Market by Company in 2021 ($ Million)
Figure 20. Global Hepatitis B Vaccination Revenue Market Share by Company in 2021
Figure 21. Global Hepatitis B Vaccination Sales Market Share by Geographic Region (2017-2022)
Figure 22. Global Hepatitis B Vaccination Revenue Market Share by Geographic Region in 2021
Figure 23. Global Hepatitis B Vaccination Sales Market Share by Region (2017-2022)
Figure 24. Global Hepatitis B Vaccination Revenue Market Share by Country/Region in 2021
Figure 25. Americas Hepatitis B Vaccination Sales 2017-2022 (Units)
Figure 26. Americas Hepatitis B Vaccination Revenue 2017-2022 ($ Millions)
Figure 27. APAC Hepatitis B Vaccination Sales 2017-2022 (Units)
Figure 28. APAC Hepatitis B Vaccination Revenue 2017-2022 ($ Millions)
Figure 29. Europe Hepatitis B Vaccination Sales 2017-2022 (Units)
Figure 30. Europe Hepatitis B Vaccination Revenue 2017-2022 ($ Millions)
Figure 31. Middle East & Africa Hepatitis B Vaccination Sales 2017-2022 (Units)
Figure 32. Middle East & Africa Hepatitis B Vaccination Revenue 2017-2022 ($ Millions)
Figure 33. Americas Hepatitis B Vaccination Sales Market Share by Country in 2021
Figure 34. Americas Hepatitis B Vaccination Revenue Market Share by Country in 2021
Figure 35. United States Hepatitis B Vaccination Revenue Growth 2017-2022 ($ Millions)
Figure 36. Canada Hepatitis B Vaccination Revenue Growth 2017-2022 ($ Millions)
Figure 37. Mexico Hepatitis B Vaccination Revenue Growth 2017-2022 ($ Millions)
Figure 38. Brazil Hepatitis B Vaccination Revenue Growth 2017-2022 ($ Millions)
Figure 39. APAC Hepatitis B Vaccination Sales Market Share by Region in 2021
Figure 40. APAC Hepatitis B Vaccination Revenue Market Share by Regions in 2021
Figure 41. China Hepatitis B Vaccination Revenue Growth 2017-2022 ($ Millions)
Figure 42. Japan Hepatitis B Vaccination Revenue Growth 2017-2022 ($ Millions)
Figure 43. South Korea Hepatitis B Vaccination Revenue Growth 2017-2022 ($ Millions)
Figure 44. Southeast Asia Hepatitis B Vaccination Revenue Growth 2017-2022 ($ Millions)
Figure 45. India Hepatitis B Vaccination Revenue Growth 2017-2022 ($ Millions)
Figure 46. Australia Hepatitis B Vaccination Revenue Growth 2017-2022 ($ Millions)
Figure 47. Europe Hepatitis B Vaccination Sales Market Share by Country in 2021
Figure 48. Europe Hepatitis B Vaccination Revenue Market Share by Country in 2021
Figure 49. Germany Hepatitis B Vaccination Revenue Growth 2017-2022 ($ Millions)
Figure 50. France Hepatitis B Vaccination Revenue Growth 2017-2022 ($ Millions)
Figure 51. UK Hepatitis B Vaccination Revenue Growth 2017-2022 ($ Millions)
Figure 52. Italy Hepatitis B Vaccination Revenue Growth 2017-2022 ($ Millions)
Figure 53. Russia Hepatitis B Vaccination Revenue Growth 2017-2022 ($ Millions)
Figure 54. Middle East & Africa Hepatitis B Vaccination Sales Market Share by Country in 2021
Figure 55. Middle East & Africa Hepatitis B Vaccination Revenue Market Share by Country in 2021
Figure 56. Egypt Hepatitis B Vaccination Revenue Growth 2017-2022 ($ Millions)
Figure 57. South Africa Hepatitis B Vaccination Revenue Growth 2017-2022 ($ Millions)
Figure 58. Israel Hepatitis B Vaccination Revenue Growth 2017-2022 ($ Millions)
Figure 59. Turkey Hepatitis B Vaccination Revenue Growth 2017-2022 ($ Millions)
Figure 60. GCC Country Hepatitis B Vaccination Revenue Growth 2017-2022 ($ Millions)
Figure 61. Manufacturing Cost Structure Analysis of Hepatitis B Vaccination in 2021
Figure 62. Manufacturing Process Analysis of Hepatitis B Vaccination
Figure 63. Industry Chain Structure of Hepatitis B Vaccination
Figure 64. Channels of Distribution
Figure 65. Distributors Profiles
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...